CCHR Demands Immediate FDA Ban on Controversial Electric Shock Behavioral Devices

The Food and Drug Administration (FDA) has officially missed its deadline to implement a federal ban on electrical stimulation devices (ESDs) used as aversive therapy for autistic and developmentally disabled individuals. These devices, which deliver high-voltage shocks to patients, have been widely condemned by human rights organizations and medical professionals as a form of torture. Despite legislative efforts by Congress to grant the FDA authority to outlaw these practices, the continued delay remains a significant barrier to protecting vulnerable populations from physical and psychological harm.

Critics, including the Citizens Commission on Human Rights (CCHR), emphasize that the use of ESDs causes extreme pain, trauma, and severe emotional distress. Survivors of the treatment have reported long-term psychological damage, describing the experience as dehumanizing and abusive. Medical experts, including the American Academy of Pediatrics, have warned that such interventions not only fail to address aggressive behaviors but often exacerbate them, posing a high risk for lasting trauma to those subjected to these harsh methods.

As global awareness regarding mental health human rights grows, the pressure on the FDA to finalize this ban continues to intensify. International bodies, such as the United Nations and the World Health Organization, have called for an end to coercive psychiatric practices that violate human dignity. Advocates argue that prioritizing patient safety over outdated and harmful behavioral modification techniques is a moral imperative that can no longer be ignored by federal regulators.